Tapewire

Nasdaq · USD

REGN

REGENERON PHARMACEUTICALS, INC.

Export transactions ↓
Tapewire entity
2010
SEC CIK
0000872589
Parsed reports
687

Last 12 months

Inside the activity.

0 purchase rows · 78 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202500
Jan 202601
Feb 2026035
Mar 2026013
Apr 202609
May 2026012
Jun 202600
Jul 202601
Aug 202602
Sep 202603
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 03, 2024 Filed Jan 4, 2024 21:19 UTC
LAROSA JOSEPH JEVP General Counsel and Secret
Exercise / conversionCommon Stock 34,000 $399.66 $13,588,440.00
Disclosure

SEC source: 0001883850-24-000006 · edgardoc.xml · nonDerivative · entry 1

LAROSA JOSEPH J · CIK 0001238303 · EVP General Counsel and Secret

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,036

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 03, 2024 Filed Jan 4, 2024 21:19 UTC
Landry Robert EEVP Finance CFO
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 1,100 $0.00 Strike: $378.98 $0.00
Disclosure

SEC source: 0001883850-24-000005 · edgardoc.xml · derivative · entry 7

Landry Robert E · CIK 0001585160 · EVP Finance CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,987

Underlying: Common Stock · 1,100 shares

Expires 2027-12-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
January 03, 2024 Filed Jan 4, 2024 21:19 UTC
Landry Robert EEVP Finance CFO
Tax withholdingCommon Stock 688 $912.30 $627,662.40
Disclosure

SEC source: 0001883850-24-000005 · edgardoc.xml · nonDerivative · entry 4

Landry Robert E · CIK 0001585160 · EVP Finance CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,448

Read SEC document
January 03, 2024 Filed Jan 4, 2024 21:19 UTC
Landry Robert EEVP Finance CFO
Exercise / conversionCommon Stock 1,100 $378.98 $416,878.00
Disclosure

SEC source: 0001883850-24-000005 · edgardoc.xml · nonDerivative · entry 3

Landry Robert E · CIK 0001585160 · EVP Finance CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,136

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 03, 2024 Filed Jan 4, 2024 21:11 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 826 $0.00 Strike: $380.95 $0.00
Disclosure

SEC source: 0001968202-24-000027 · edgardoc.xml · derivative · entry 4

Bassler Bonnie L · CIK 0001683607 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,654

Underlying: Common Stock · 826 shares

Expires 2028-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 11, 2023.

F3 · derivative.exercise_date: The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.

Read SEC document
January 03, 2024 Filed Jan 4, 2024 21:11 UTC SaleCommon Stock 826 $914.00 $754,964.00
Disclosure

SEC source: 0001968202-24-000027 · edgardoc.xml · nonDerivative · entry 3

Bassler Bonnie L · CIK 0001683607 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,382

F2 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 11, 2023.

Read SEC document
January 03, 2024 Filed Jan 4, 2024 21:11 UTC Exercise / conversionCommon Stock 826 $380.95 $314,664.70
Disclosure

SEC source: 0001968202-24-000027 · edgardoc.xml · nonDerivative · entry 2

Bassler Bonnie L · CIK 0001683607 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,208

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 11, 2023.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:20 UTC
YANCOPOULOS GEORGEDirector · Bd. Co-Chair, President & CSO
SaleCommon Stock 16,848 $900.00 $15,163,200.00
Disclosure

SEC source: 0001883850-24-000007 · edgardoc.xml · nonDerivative · entry 1

YANCOPOULOS GEORGE · CIK 0001226690 · Director · Bd. Co-Chair, President & CSO

10b5-1 filing: Plan reported

Ownership: Indirect · By Trust for Chldn.

Disclosed balance after: 180,000

F1 · kind: Disposition/acquisition made pursuant to plans intended to comply with Rule 10b5-1(c) adopted on November 29, 2022.

F2 · ownership.nature: As investment trustee of trusts for the benefit of the reporting person's children.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:19 UTC
Landry Robert EEVP Finance CFO
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 650 $0.00 Strike: $378.98 $0.00
Disclosure

SEC source: 0001883850-24-000005 · edgardoc.xml · derivative · entry 6

Landry Robert E · CIK 0001585160 · EVP Finance CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,087

Underlying: Common Stock · 650 shares

Expires 2027-12-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:19 UTC
Landry Robert EEVP Finance CFO
Tax withholdingCommon Stock 421 $888.34 $373,991.14
Disclosure

SEC source: 0001883850-24-000005 · edgardoc.xml · nonDerivative · entry 2

Landry Robert E · CIK 0001585160 · EVP Finance CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,036

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:19 UTC
Landry Robert EEVP Finance CFO
Exercise / conversionCommon Stock 650 $378.98 $246,337.00
Disclosure

SEC source: 0001883850-24-000005 · edgardoc.xml · nonDerivative · entry 1

Landry Robert E · CIK 0001585160 · EVP Finance CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,457

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:17 UTC
McCourt MarionEVP Commercial
SaleCommon Stock 274 $873.91 $239,451.34
Disclosure

SEC source: 0001883850-24-000004 · edgardoc.xml · nonDerivative · entry 1

McCourt Marion · CIK 0001663758 · EVP Commercial

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,062

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 16, 2023.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:17 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 508 $0.00 Strike: $888.34 $0.00
Disclosure

SEC source: 0001883850-24-000003 · edgardoc.xml · derivative · entry 2

Schenkein David P · CIK 0001578200 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 508

Underlying: Common Stock · 508 shares

Expires 2034-01-02

F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:17 UTC GrantCommon Stock 42 $0.00 $0.00
Disclosure

SEC source: 0001883850-24-000003 · edgardoc.xml · nonDerivative · entry 1

Schenkein David P · CIK 0001578200 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 282

F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:16 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 508 $0.00 Strike: $888.34 $0.00
Disclosure

SEC source: 0001883850-24-000002 · edgardoc.xml · derivative · entry 2

Guarini Kathryn · CIK 0001992352 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 508

Underlying: Common Stock · 508 shares

Expires 2034-01-02

F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:16 UTC GrantCommon Stock 42 $0.00 $0.00
Disclosure

SEC source: 0001883850-24-000002 · edgardoc.xml · nonDerivative · entry 1

Guarini Kathryn · CIK 0001992352 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 282

F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:15 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,607 $0.00 Strike: $888.34 $0.00
Disclosure

SEC source: 0001883850-24-000001 · edgardoc.xml · derivative · entry 2

Thompson Craig B. · CIK 0001423419 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,607

Underlying: Common Stock · 1,607 shares

Expires 2034-01-02

F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:15 UTC GrantCommon Stock 135 $0.00 $0.00
Disclosure

SEC source: 0001883850-24-000001 · edgardoc.xml · nonDerivative · entry 1

Thompson Craig B. · CIK 0001423419 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 454

F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:11 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,607 $0.00 Strike: $888.34 $0.00
Disclosure

SEC source: 0001968202-24-000029 · edgardoc.xml · derivative · entry 2

COLES N ANTHONY · CIK 0001197018 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,607

Underlying: Common Stock · 1,607 shares

Expires 2034-01-02

F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:11 UTC GrantCommon Stock 135 $0.00 $0.00
Disclosure

SEC source: 0001968202-24-000029 · edgardoc.xml · nonDerivative · entry 1

COLES N ANTHONY · CIK 0001197018 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,393

F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:11 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,607 $0.00 Strike: $888.34 $0.00
Disclosure

SEC source: 0001968202-24-000027 · edgardoc.xml · derivative · entry 5

Bassler Bonnie L · CIK 0001683607 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,607

Underlying: Common Stock · 1,607 shares

Expires 2034-01-02

F4 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:11 UTC GrantCommon Stock 135 $0.00 $0.00
Disclosure

SEC source: 0001968202-24-000027 · edgardoc.xml · nonDerivative · entry 1

Bassler Bonnie L · CIK 0001683607 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,382

F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:11 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,607 $0.00 Strike: $888.34 $0.00
Disclosure

SEC source: 0001968202-24-000028 · edgardoc.xml · derivative · entry 5

Zoghbi Huda Y · CIK 0001681643 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,607

Underlying: Common Stock · 1,607 shares

Expires 2034-01-02

F4 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:11 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 1,117 $0.00 Strike: $391.92 $0.00
Disclosure

SEC source: 0001968202-24-000028 · edgardoc.xml · derivative · entry 4

Zoghbi Huda Y · CIK 0001681643 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,117 shares

Expires 2026-09-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 5, 2023.

F3 · derivative.exercise_date: The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:11 UTC GrantCommon Stock 135 $0.00 $0.00
Disclosure

SEC source: 0001968202-24-000028 · edgardoc.xml · nonDerivative · entry 3

Zoghbi Huda Y · CIK 0001681643 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,382

F2 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:11 UTC SaleCommon Stock 1,117 $900.00 $1,005,300.00
Disclosure

SEC source: 0001968202-24-000028 · edgardoc.xml · nonDerivative · entry 2

Zoghbi Huda Y · CIK 0001681643 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,247

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 5, 2023.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:11 UTC Exercise / conversionCommon Stock 1,117 $391.92 $437,774.64
Disclosure

SEC source: 0001968202-24-000028 · edgardoc.xml · nonDerivative · entry 1

Zoghbi Huda Y · CIK 0001681643 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,364

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 5, 2023.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:10 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,607 $0.00 Strike: $888.34 $0.00
Disclosure

SEC source: 0001968202-24-000026 · edgardoc.xml · derivative · entry 2

POON CHRISTINE A · CIK 0001189014 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,607

Underlying: Common Stock · 1,607 shares

Expires 2034-01-02

F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:10 UTC GrantCommon Stock 135 $0.00 $0.00
Disclosure

SEC source: 0001968202-24-000026 · edgardoc.xml · nonDerivative · entry 1

POON CHRISTINE A · CIK 0001189014 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,172

F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:08 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,607 $0.00 Strike: $888.34 $0.00
Disclosure

SEC source: 0001968202-24-000025 · edgardoc.xml · derivative · entry 15

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,607

Underlying: Common Stock · 1,607 shares

Expires 2034-01-02

F12 · derivative.exercise_date: On the date of the Company's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:08 UTC GrantCommon Stock 135 $0.00 $0.00
Disclosure

SEC source: 0001968202-24-000025 · edgardoc.xml · nonDerivative · entry 14

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,482

F11 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Company's common stock.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:08 UTC SaleCommon Stock 3 $904.49 $2,713.47
Disclosure

SEC source: 0001968202-24-000025 · edgardoc.xml · nonDerivative · entry 13

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,347

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 7, 2023.

F10 · price: Represents volume-weighted average price of sales of 3 shares of Company stock on January 2, 2024 at prices ranging from $904.00 to $904.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2024 at each separate price.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:08 UTC SaleCommon Stock 13 $903.49 $11,745.37
Disclosure

SEC source: 0001968202-24-000025 · edgardoc.xml · nonDerivative · entry 12

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,350

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 7, 2023.

F9 · price: Represents volume-weighted average price of sales of 13 shares of Company stock on January 2, 2024 at prices ranging from $903.13 to $903.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2024 at each separate price.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:08 UTC SaleCommon Stock 10 $902.37 $9,023.70
Disclosure

SEC source: 0001968202-24-000025 · edgardoc.xml · nonDerivative · entry 11

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,363

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 7, 2023.

F8 · price: Represents volume-weighted average price of sales of 10 shares of Company stock on January 2, 2024 at prices ranging from $902.14 to $902.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2024 at each separate price.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:08 UTC SaleCommon Stock 9 $901.46 $8,113.14
Disclosure

SEC source: 0001968202-24-000025 · edgardoc.xml · nonDerivative · entry 10

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,373

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 7, 2023.

F7 · price: Represents volume-weighted average price of sales of 9 shares of Company stock on January 2, 2024 at prices ranging from $901.03 to $901.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2024 at each separate price.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:08 UTC SaleCommon Stock 29 $900.59 $26,117.11
Disclosure

SEC source: 0001968202-24-000025 · edgardoc.xml · nonDerivative · entry 9

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,382

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 7, 2023.

F6 · price: Represents volume-weighted average price of sales of 29 shares of Company stock on January 2, 2024 at prices ranging from $900.00 to $900.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2024 at each separate price.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:08 UTC SaleCommon Stock 14 $899.66 $12,595.24
Disclosure

SEC source: 0001968202-24-000025 · edgardoc.xml · nonDerivative · entry 8

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,411

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 7, 2023.

F5 · price: Represents volume-weighted average price of sales of 14 shares of Company stock on January 2, 2024 at prices ranging from $899.08 to $899.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2024 at each separate price.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:08 UTC SaleCommon Stock 6 $898.76 $5,392.56
Disclosure

SEC source: 0001968202-24-000025 · edgardoc.xml · nonDerivative · entry 7

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,425

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 7, 2023.

F4 · price: Represents volume-weighted average price of sales of 6 shares of Company stock on January 2, 2024 at prices ranging from $898.45 to $898.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2024 at each separate price.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:08 UTC SaleCommon Stock 3 $897.41 $2,692.23
Disclosure

SEC source: 0001968202-24-000025 · edgardoc.xml · nonDerivative · entry 6

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,431

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 7, 2023.

F3 · price: Represents volume-weighted average price of sales of 3 shares of Company stock on January 2, 2024 at prices ranging from $897.35 to $897.54. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2024 at each separate price.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:08 UTC SaleCommon Stock 8 $896.47 $7,171.76
Disclosure

SEC source: 0001968202-24-000025 · edgardoc.xml · nonDerivative · entry 5

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,434

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 7, 2023.

F2 · price: Represents volume-weighted average price of sales of 8 shares of Company stock on January 2, 2024 at prices ranging from $896.21 to $896.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2024 at each separate price.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:08 UTC SaleCommon Stock 1 $892.00 $892.00
Disclosure

SEC source: 0001968202-24-000025 · edgardoc.xml · nonDerivative · entry 4

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,442

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 7, 2023.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:08 UTC SaleCommon Stock 1 $887.13 $887.13
Disclosure

SEC source: 0001968202-24-000025 · edgardoc.xml · nonDerivative · entry 3

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,443

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 7, 2023.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:08 UTC SaleCommon Stock 2 $886.26 $1,772.52
Disclosure

SEC source: 0001968202-24-000025 · edgardoc.xml · nonDerivative · entry 2

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,444

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 7, 2023.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:08 UTC SaleCommon Stock 1 $873.91 $873.91
Disclosure

SEC source: 0001968202-24-000025 · edgardoc.xml · nonDerivative · entry 1

RYAN ARTHUR F · CIK 0001187443 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,446

F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 7, 2023.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:07 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,607 $0.00 Strike: $888.34 $0.00
Disclosure

SEC source: 0001968202-24-000024 · edgardoc.xml · derivative · entry 5

SING GEORGE L · CIK 0001225471 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,607

Underlying: Common Stock · 1,607 shares

Expires 2034-01-02

F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:07 UTC GrantCommon Stock 135 $0.00 $0.00
Disclosure

SEC source: 0001968202-24-000024 · edgardoc.xml · nonDerivative · entry 1

SING GEORGE L · CIK 0001225471 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,349

F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:07 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,607 $0.00 Strike: $888.34 $0.00
Disclosure

SEC source: 0001968202-24-000023 · edgardoc.xml · derivative · entry 2

GOLDSTEIN JOSEPH L · CIK 0001225474 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,607

Underlying: Common Stock · 1,607 shares

Expires 2034-01-02

F2 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:07 UTC GrantCommon Stock 135 $0.00 $0.00
Disclosure

SEC source: 0001968202-24-000023 · edgardoc.xml · nonDerivative · entry 1

GOLDSTEIN JOSEPH L · CIK 0001225474 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,382

F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:06 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 1,607 $0.00 Strike: $888.34 $0.00
Disclosure

SEC source: 0001968202-24-000022 · edgardoc.xml · derivative · entry 4

BROWN MICHAEL S · CIK 0001174475 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,607

Underlying: Common Stock · 1,607 shares

Expires 2034-01-02

F3 · derivative.exercise_date: On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:06 UTC GrantCommon Stock 135 $0.00 $0.00
Disclosure

SEC source: 0001968202-24-000022 · edgardoc.xml · nonDerivative · entry 1

BROWN MICHAEL S · CIK 0001174475 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,382

F1 · kind: Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.